US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

23.74

-0.0047-0.02%

Post-market: 23.760.0218+0.09%18:12 EDT

Volume:537

Turnover:12.76K

Market Cap:4.04M

PE:- -

High:23.85

Open:23.85

Low:23.66

Close:23.74

52wk High:34.36

52wk Low:19.00

Shares:170.00K

Float Shares:170.00K

Volume Ratio:0.89

T/O Rate:0.32%

Dividend:1.56

Dividend Rate:6.56%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug

MT Newswires Live

Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials

MT Newswires Live

The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular

Bellwether Stocks Movement

Novo Nordisk (0QIU) Receives a Hold from Barclays

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Sector Update: Healthcare

MT Newswires Live

Novo Nordisk Foundation to Set Up Quantum Chip Facility

MT Newswires Live

Surge in Crypto ETFs as Hawkish Fed Concerns Ease

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/NVOH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":23.7382,"timestamp":1789761600000,"preClose":23.7429,"halted":0,"volume":537,"hourTrading":{"tag":"盘后","latestPrice":23.76,"preClose":23.7382,"latestTime":"18:12 EDT","volume":48,"amount":1168.7056,"timestamp":1789769543624,"change":0.0218,"changeRate":0.000918,"amplitude":0},"delay":0,"changeRate":-0.00019795391464394428,"floatShares":170001,"shares":170001,"eps":0,"marketStatus":"Market Closed","change":-0.0047,"latestTime":"09-18 16:00:00 EDT","open":23.85,"high":23.85,"low":23.655,"amount":12757,"amplitude":0.008213,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":23.7429,"nav":23.692545,"aum":4027756.342545,"dividendRate":0.065645,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.76,"preClose":23.7382,"latestTime":"18:12 EDT","volume":48,"amount":1168.7056,"timestamp":1789769543624,"change":0.0218,"changeRate":0.000918,"amplitude":0},"volumeRatio":0.8871465351438873,"impliedVol":0.243,"impliedVolPercentile":0.5678},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":170001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8871465351438873,"shares":170001,"dividePrice":1.5583,"high":23.85,"amplitude":0.008213,"preClose":23.7429,"low":23.655,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":23.7382,"eps":0,"divideRate":0.065645,"volume":537,"delay":0,"ttmEps":0,"open":23.85,"prevYearClose":27.4362,"prevWeekClose":23.4261,"prevMonthClose":24.5859,"prevQuarterClose":26.0576,"fiveDayClose":23.4261,"twentyDayClose":24.9612,"sixtyDayClose":25.9721},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-09-16","symbol":"NVOH","amount":0.02979,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-23"},{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"},{"executeDate":"2026-09-16","recordDate":"2026-09-16","paymentDate":"2026-09-23","value":0.02979,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665832664","title":"Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665832664","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665832664?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:12","pubTimestamp":1788858753,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Monday its phase 3 Step Young trial evaluating once-weekly semaglutide in children aged six to under 12 with obesity met its primary endpoint.The treatment produced a superior reduction in body mass index at 68 weeks compared with a placebo, the company said.The study also achieved its secondary endpoint for body mass index classification improvement, resulting in 40.4% of treated patients no longer meeting the criteria for obesity, it said.Safety results aligned with previous trials and showed no adverse effects on growth or pubertal development, Novo Nordisk said.Shares of the company were down 1.2% in Tuesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4532","NVO","OZEM","BK4599","BK4588","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","PPH","NVOC","BK4007","NVOX","THNR","LU1093756325.SGD","LU1093756168.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325786","title":"Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325786","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665325786?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:57","pubTimestamp":1788857878,"startTime":"0","endTime":"0","summary":"Novo Nordisk  has stopped two additional trials of its experimental cardiovascular drug, ziltivekimab, after an independent committee found a low chance they would produce a different result from an earlier failed study, Reuters reported Monday.The trials, which tested the drug in heart failure patients, will end early, the company told MT Newswires. It added that patients will continue through to their 3-months follow-up as already planned.Novo said its trial testing ziltivekimab in an acute setting following a heart attack will continue as planned with results expected in H1 2027.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","BK4599","NVOH","BK4007","LU0154236417.USD","NVOX","NVOC","PPH","LU1093756325.SGD","OZEM","IE00BKVL7J92.USD","BK4532","BK4585","THNR","LU1093756168.USD","BK4588","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106138144","title":"The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular","url":"https://stock-news.laohu8.com/highlight/detail?id=1106138144","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106138144?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:29","pubTimestamp":1788852576,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1021.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/1021.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVOC","NVOH","NVS","NVOX"],"isVideo":true,"video":{"duration":72,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/1021/render_1021_1788852029273.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1021.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/1021/tts/voiceover_9390fdb8b84958e8.mp3","isAI":true},"gpt_icon":0},{"id":"2665328428","title":"Novo Nordisk (0QIU) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665328428?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:25","pubTimestamp":1788852330,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Hold rating on Novo Nordisk today and set a price target of DKK300.00. According to TipRanks, Gordon...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0154236417.USD","BK4588","LU1093756168.USD","LU1093756325.SGD","PPH","IE00BKVL7J92.USD","NVOH","NVOX","BK4599","THNR","OZEM","BK4007","IE00BZ1G4Q59.USD","NVOC","BK4532","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665631001","title":"Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2665631001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665631001?lang=en_us&edition=fundamental","pubTime":"2026-09-08 05:40","pubTimestamp":1788817216,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","NVOC","PPH","BK4585","BK4007","BK4588","BK4532","LU0154236417.USD","NVOH","NVOX","IE00BKVL7J92.USD","THNR","LU1093756168.USD","OZEM","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376683","title":"Yen advances to six-month high, chip stocks rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376683","media":"Nicholas Reynolds / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376683?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:14","pubTimestamp":1788804840,"startTime":"0","endTime":"0","summary":"The yen extended Monday's advance to reach the strongest level since February, aided by rising expectations of a Bank of Japan interest-rate increase next week.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["NVOH","IE00BN8TJ469.HKD","LU0234570918.USD","LU0127658192.USD","SG9999018857.SGD","LU0234572021.USD","SGXZ81514606.USD","LU0868494617.USD","LU2237438978.USD","LU1988902786.USD","OZEM","LU1720051017.SGD","LU1267930730.SGD","LU0211326839.USD","LU1989764748.USD","LU0256863811.USD","SG9999001424.SGD","LU0672654240.SGD","BK4207","LU2087625088.SGD","LU2211815571.USD","SG9999015945.SGD","LU0345774631.USD","IE00BKDWB100.SGD","IE00BFXG0V08.USD","LU2213496289.HKD","IE0034235188.USD","LU1674673428.USD","LU1496350502.SGD","IE00BHPRN162.USD","LU0976567544.SGD","LU2462157665.USD","LU2430703095.HKD","TPOR","BK4533","LU2237443895.HKD","LU0251132253.USD","LU2244417387.USD","GB00BDT5M118.USD","LU0348723411.USD","IE00BDRTCR15.USD","LU1935042215.USD","LU2237443978.SGD","IE00B1XK9C88.USD","LU1548497426.USD","LU1894683348.USD","LU0070302665.USD","IE0004445239.USD","LU2023251221.USD","LU1366333091.USD","LU0211327993.USD","LU0289739343.SGD","BK4588","BK4554","IE00B775SV38.USD","LU2236285917.USD","LU1116320901.HKD","LU2168564495.EUR","BK4007","BK4528","LU1935042488.USD","LU0320765646.SGD","LU1934455194.USD","IE000M9KFDE8.USD","IE00BDCRKT87.USD","LU1064131342.USD","LU1267930490.SGD","LU1629891620.HKD","LU1551013342.USD","BK4599","LU0708995401.HKD","LU0289961442.SGD","LU0444971666.USD","LU0069063385.USD","LU2168564149.EUR","LU0353189763.USD","LU2381873111.SGD","LU2543165471.USD","LU1914381329.SGD","LU0648001328.SGD","LU0187121727.USD","LU1429558221.USD","LU0203347892.USD","IYG","LU0965509010.AUD","LU0345774391.USD","LU0965509283.SGD","IE0002270589.USD","IE00BJTD4V19.USD","ORCS","LU2326559502.SGD","LU0878866978.SGD","LU2404859667.USD","GB00B4QBRK32.GBP","LU2089283258.USD","LU2360107325.USD","LU0211331839.USD","PPH","BK4550","BK4230","LU0690374615.EUR","LU1691799644.USD","LU0957791311.USD","ORCZ","LU0211326755.USD","LU2237443465.HKD","LU0345770993.USD","LU1815333072.USD","BK4592","LU1244550221.USD","LU0149725797.USD","JPO","SG9999000418.SGD","JPM","LU0889565833.HKD","LU0198837287.USD","LU2505996509.AUD","LU2360032135.SGD","LU0476273544.USD","BK4534","LU1035773651.USD","BK4023","LU0208291251.USD","IE00BZ199S13.USD","UBRL","LU1145028129.USD","LU1934455863.HKD","IE00BQXX3D17.EUR","BK4538","LU1668664300.SGD","BK4566","BK4532","LU1316542783.SGD","LU0310799852.SGD","LU0345769128.USD","LU2458330243.SGD","LU2552382215.SGD","LU1280957306.USD","LU1046421795.USD","IE00BJLML261.HKD","LU0314106906.USD","LU0642271901.SGD","LU0792757196.USD","BK4543","SG9999015952.SGD","LU1496350171.SGD","LU0107464264.USD","LU0170899867.USD","LU2023250843.SGD","LU0553294199.USD","LU1823568750.SGD","LU1366192091.USD","LU1069347547.HKD","LU0472753341.HKD","LU1119994496.HKD","LU0267386448.USD","LU0323591593.USD","LU2458330169.SGD","GB00B4LPDJ14.GBP","KBWB","IE00BQXX3F31.USD","LU1934455277.USD","LU0056508442.USD","LU1244550494.USD","LU1093756325.SGD","IGV","LU0265550946.USD","LU0861579265.USD","LU2360106780.USD","IE00B19Z9505.USD","IE00BMPRXR70.SGD","IE00BQXX3C00.GBP","ORCX","BK4503","LU0640476718.USD","LU0859254822.USD","LU2552382058.USD","LU0314104364.USD","LU0965509101.SGD","SGXZ31699556.SGD","LU2106854487.HKD","UBER","LU0175139822.USD","LU0109391861.USD","LU0289960550.SGD","LU0068578508.USD","LU0971096721.USD","LU0256863902.USD","SG9999014914.USD","LU1983260115.SGD","LU0157215616.USD","LU0889566641.SGD","LU0942090050.USD","LU2242649171.HKD","LU0320765059.SGD","LU0552385451.USD","LU0949170772.SGD","LU2264538146.SGD","BK4585","IE00BWXC8680.SGD","LU0689472784.USD","FDRV","LU0683600562.USD","LU0081259029.USD","LU1861214812.USD","IE00BYQQ9H92.USD","NVOC","ADBG","LU0211328371.USD","LU2237957811.SGD","LU1814569148.SGD","IE00B19Z3581.USD","LU1989772923.USD","TFNS","LU0353189680.USD","LU0545039389.USD","ADBU","LU1551013425.SGD","IE00BJTD4N35.SGD","LU2168564222.USD","LU0690374961.EUR","LU1712237335.SGD","LU1989764664.SGD","IE00B1BXHZ80.USD","LU2125154778.USD","LU1861219969.SGD","LU0980610538.SGD","SGXZ99366536.SGD","LU1642822529.SGD","LU1506573853.SGD","SG9999014898.SGD","LU2237957902.USD","IE0009356076.USD","BK4097","LU1674673691.USD","LU0964807845.USD","LU2896262040.SGD","BK4567","IYF","LU1084165304.USD","LU0345769631.USD","IE00BLSP4239.USD","LU2108987350.USD","IE00BMPRXQ63.HKD","LU0265550359.USD","LU1917777945.USD","ADBE","JPMO","LU2746668461.USD","BK4504","LU2097829019.USD","LU2456880835.USD","LU1670627923.USD","LU2237443622.USD","SG9999011175.SGD","SG9999014880.SGD","LU0345770308.USD","LU1623119135.USD","SG9999015986.USD","LU0320765489.SGD","LU1974910355.USD","LU0082616367.USD","LU2089284900.SGD","LU1720051108.HKD","LU0130102774.USD","LU0496365809.HKD","LU2552382132.HKD","BK4527","LU2095319765.USD","LU0444973449.USD","LU2404859741.USD","LU1633808545.USD","IE00B5949003.HKD","BK4505","LU1778281490.HKD","IE00B5TLWC47.USD","SG9999018865.SGD","LU0820562030.AUD","WNDR","IE00B19Z3B42.SGD","LU0719512351.SGD","IE00BYXW3230.USD","SG9999017495.SGD","IE0034235303.USD","LU0342679015.USD","LU1435385759.SGD","LU2746668974.SGD","LU1935042991.SGD","LU0006306889.USD","BK4516","SORCLmain","LU1852331112.SGD","LU0158827948.USD","LU2237443549.SGD","BK4536","ORCU","IE00BZ1G4Q59.USD","LU0787776722.HKD","LU0661504455.SGD","LU0557290698.USD","LU1670628061.USD","LU2168563687.JPY","LU2430703251.USD","LU0965508806.USD","LU2250418816.HKD","LU2023250330.USD","SG9999015978.USD","LU2417539215.USD","IE00BBT3K403.USD","IE00BK4W5M84.HKD","SG9999014906.USD","LU1989772840.SGD","LU0238689110.USD","LU2054465674.USD","LU0820561818.USD","OGIG","LU0943347566.SGD","BK4551","LU0048584097.USD","THNR","UYG","IE00BK4W5L77.USD","LU2237443382.USD","LU2756315318.SGD","LU0210536198.USD","LU0106261372.USD","LU0738911758.USD","IXG","LU1803068979.SGD","IE00BFXG1179.USD","LU2210150020.SGD","LU0154236417.USD","LU1363072403.SGD","LU1894683264.USD","LU1244550577.SGD","LU2430703178.SGD","SG9999002224.SGD","LU0215105999.USD","LU0957808578.USD","LU1201861249.SGD","IYT","IE00B7SZLL34.SGD","BK4581","LU1003077747.HKD","LU1935043023.USD","LU2125154935.USD","ORAC","BK4022","LU0057025933.USD","FTXO","LU2168564065.EUR","LU2210149790.SGD","IE00BMPRXN33.USD","LU1037948897.HKD","NVOX","LU1261432733.SGD","LU0061474960.USD","LU1235294995.USD","LU1093756168.USD","LU0820561909.HKD","LU0433182093.SGD","LU0985489474.SGD","LU0109392836.USD","LU2505996681.GBP","VFH","LU2592432038.USD","SGXZ51526630.SGD","LU0106831901.USD","LU1116320737.USD","LU0203345920.USD","ORCL","IE00BFMHRM44.USD","LU1032466523.USD","LU1267930813.SGD","LU1815336760.USD","NVO","IE00B3S45H60.SGD","LU2317271919.USD","LU1935043536.SGD","XLF","IE00BKVL7J92.USD","IE00BLSP4452.SGD","LU2756315664.SGD","LU2860962120.EUR","IE0034235295.USD","SG9999002232.USD","LU0511384066.AUD","LU0417517546.SGD","LU0882574139.USD","SG9999003800.SGD","TRUF","FNCL","LU1037948541.HKD","LU2357627491.SGD","UBEW","BK4535","LU0868494708.USD","LU1489326972.SGD","TDIV","LU1162221912.USD","LU2357305700.SGD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665109773","title":"Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665109773","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665109773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:10","pubTimestamp":1788804610,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","LU0154236417.USD","BK4585","LU1093756325.SGD","NVO","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4599","THNR","BK4588","NVOX","OZEM","PPH","NVOH","BK4532","NVOC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665862310","title":"Novo Nordisk (NVO) Hit by Another Heart Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665862310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665862310?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:56","pubTimestamp":1788800218,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","NVO","OZEM","BK4599","BK4588","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","PPH","NVOC","BK4007","NVOX","THNR","LU1093756325.SGD","LU1093756168.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731749","title":"Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731749?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:02","pubTimestamp":1788796920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B were flat  at DKK298.95 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.3% to 2,710.84.The stock's rise  snapped a two-day losing streak.The company closed DKK111.00 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 1,797,150, compared to the 50-day average trading volume of 4,122,224.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","NVOC","OZEM","LU1093756168.USD","BK4007","THNR","BK4585","IE00BKVL7J92.USD","NVO","NVOX","PPH","BK4599","NVOH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131175","title":"Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131175?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:32","pubTimestamp":1788784376,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) shares in Copenhagen edged lower on Monday afternoon. This came even after the Danish pharma giant said in a statement that i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","IE00BZ1G4Q59.USD","NVOX","NVO","NVOH","BK4599","IE00BKVL7J92.USD","THNR","BK4007","BK4585","OZEM","BK4588","LU1093756325.SGD","NVOC","PPH","LU1093756168.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUH","FHLC","PJP","FXH","MEDI","PINK","NVOX","THNR","XLVI","BGIA","NBDS","RSPH","NVOH","CURE","NVOC","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319474","title":"Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319474","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319474?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:42","pubTimestamp":1788781356,"startTime":"0","endTime":"0","summary":"Novo scraps two more heart drug trials, further dimming growth beyond obesitySept 7 (Reuters)-Novo NordiskNOVOb.COsaid on Monday it had halted two additional trials of its experimental cardiovascular ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL6N44Z0K2:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","NVOX","NVOH","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398326","title":"Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398326","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398326?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:23","pubTimestamp":1788740626,"startTime":"0","endTime":"0","summary":"The latest update is out from LBT Innovations Limited ( ($AU:CC5) ). Clever Culture Systems Ltd, an Adelaide-based specialist in AI microbiology au...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","OZEM","NVOC","LU1093756325.SGD","IE00BKVL7J92.USD","THNR","BK4007","BK4588","BK4532","BK7007","IE00BZ1G4Q59.USD","CC5.AU","LU0154236417.USD","PPH","NVO","BK4585","LU1093756168.USD","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665835320","title":"Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665835320","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665835320?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539471,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study A Study Investigating Safety, Tolerability, Pharmacokinetics and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVO","BK4007","OZEM","BK4532","BK4588","IE00BZ1G4Q59.USD","THNR","LU0154236417.USD","BK4599","NVOC","NVOH","PPH","IE00BKVL7J92.USD","LU1093756325.SGD","BK4585","LU1093756168.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665353356","title":"Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665353356","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665353356?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:02","pubTimestamp":1788537720,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B dropped 0.9% to DKK298.90 Friday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,702.17.This was the stock's second consecutive day of losses.The company closed DKK111.05 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 3,129,002, compared to the 50-day average trading volume of 4,174,340.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","BK4588","NVOH","NVOX","NVOC","BK4585","OZEM","PPH","THNR","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","LU1093756168.USD","LU0154236417.USD","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664533403","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664533403","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664533403?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:00","pubTimestamp":1788526844,"startTime":"0","endTime":"0","summary":"Healthcare stocks were declining pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF  down 0.3% and the iShares Biotechnology ETF  0.2% lower.Novo Nordisk's  charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Shares of Novo Nordisk were down more than 1% premarket.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","BK4007","BK4588","BK4581","NVOH","NVO","BK4585","THNR","OZEM","PPH","XBI","LABU","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","XLV","BK4599","LU0154236417.USD","NVOC","IBB","NVOX","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874873","title":"Novo Nordisk Foundation to Set Up Quantum Chip Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874873","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874873?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:10","pubTimestamp":1788509441,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said Friday.The new plant aims to develop manufacturing equipment for the production of quantum chips.The facility will include laboratory space for nano-fabrication of quantum materials, testing, chip assembly and packaging, along with vacuum manufacturing capabilities, offering wafer fabrication services for customers worldwide, the organizations said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOX","BK4532","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","PPH","LU0154236417.USD","OZEM","BK4585","BK4599","BK4007","THNR","BK4588","NVOC","LU1093756168.USD","NVOH","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139354085","title":"Surge in Crypto ETFs as Hawkish Fed Concerns Ease","url":"https://stock-news.laohu8.com/highlight/detail?id=1139354085","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139354085?lang=en_us&edition=fundamental","pubTime":"2026-09-04 14:03","pubTimestamp":1788501803,"startTime":"0","endTime":"0","summary":"Cryptocurrency-linked exchange-traded funds listed in Hong Kong posted sharp gains on Tuesday, tracking a broad rally in digital assets after dovish comments from a Federal Reserve official dampened...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4535","07711","NCIQ","XBTY","BK4600","BK4588","BK4082","BTCZ","GCPU","RGYY","SSO","DIME","XW","VRTL","BLCK","IBIT","CBOO","FINX","LITX","CRY","BK4595","BRRR","VRC","BK4112","HODL","BETE","SPDN","SH","BK4539","LU2360107671.USD","GBTC","BTRN","BK4596","BK4554","FIAT","MMAX","BTCC","BLOK","BK4601","IBLC","SPUU","BKCH","NBIZ","SPYU","EZBC","NBIG","LU1861559042.SGD","ETNG","STCE","BK4550","BK4594","SPXL","BITQ","GDLC","BITY","BAGY","OSSL","BFJL","NEBX","ARKB","NBIC","07399","LITU","SIMX","BITW","DAPP","BK4585","TEKX","BTCW","SPYH","CONL","DMAX","LABX","COIW","BTCL","CONX","ICOI","MVV","YSPY","ONTX","YBTC","SPYM","BITU","BITO","BITX","CBXJ","NBIL","LITG","SPXU","COIG","COII","BK4516","SPYQ","LU1861217088.USD","SDS","CBOY","FDN","ALA","SPY","VOO","LU1861220207.SGD","SMAX","CONI","CONY","NVTX","BTCI","07311","COIO","CBXY","BITI","RGTU","LU1861558580.USD","COIX","LITC","CBOA","HIBL","BCCC","COIN","QBF","BK4551","COIA","TXXH","ETTY","IVV","CBTA","CBXO","DEFI","09711","SPXS","FBTC","RGTC","MAXI","COZX","MNRS","NVOH","UPRO","LFGY","BTF","SAA","LITZ","09311","BPI","BETH","BFAP","CBTJ","FDIG","BITB","NVTC","CBOJ","BTC","BTCO","RGTX","CBTO","NVOC","NVOX","COYY","HECO","DFII","SBIT","RGTZ","07799","CBTY","BLOX","TEUP","CBXA","CRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664848475","title":"Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664848475","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664848475?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:02","pubTimestamp":1788364920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 2.6% to DKK301.65 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,678.58.This was the stock's second consecutive day of gains.The company closed DKK108.30 below its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 4,095,568, compared to the 50-day average trading volume of 4,185,751.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","LU1093756325.SGD","BK4585","IE00BKVL7J92.USD","OZEM","NVO","NVOX","PPH","LU1093756168.USD","THNR","BK4532","BK4588","IE00BZ1G4Q59.USD","NVOH","BK4007","BK4599","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081008","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081008","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081008?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:13","pubTimestamp":1788362021,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.50% to 1,960.43 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and semiconductor company Sequans Communications , which rose 4% and 3.6% respectively. They were followed by pharmaceutical company Novo Nordisk  and lender ING Group , which were up 3.5% and 2.9% respectively.The decliners from continental Europe were led by internet browser company Opera  and petroleum refiner Equinor , which dropped  2.3% and 1.5% respectively. They were followed by telecommunications companies Nokia  and Ericsson , which lost 0.8% and 0.7% respectively.The gainers from the UK were led by hospitality company InterContinental Hotels Group  and biopharmaceutical company Bicycle Therapeutics , which advanced 4.1% and 3.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals  and mining company BHP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","LU1093756325.SGD","SQNS","WPP","EVAX","BK4141","ERIC","BDRX","BK4168","NVOC","LU0300736062.USD","BK4547","LU0300736492.USD","IE00BKVL7J92.USD","BK4020","BK4515","BK4201","EQNR","LU0006061336.USD","THNR","IHG","BK4207","BK4111","NVOH","BK4532","BK4591","BK4599","ING","NVO","SLX","IE00BZ1G4Q59.USD","NVOX","BK4082","IE00BMPRXR70.SGD","LFGY","BK4585","BK4505","BCYC","BK4023","PSO","BK4139","BHP","TRIB","BK4204","LNOK","LU1093756168.USD","COAL","BK4554","BK4588","NOK","OZEM","BK4142","OPRA","MREO","PPH","BK4007","BK4009","IE00BMPRXN33.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}